Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.5 EUR | +1.12% | -0.75% | +15.54% |
May. 30 | Merck KGaA: memorandum of understanding with South Korean institute | CF |
May. 30 | Merck KGaA Signs Korea Science Research Pact | DJ |
Sales 2024 * | 21.3B 23.1B | Sales 2025 * | 22.59B 24.5B | Capitalization | 72.39B 78.51B |
---|---|---|---|---|---|
Net income 2024 * | 3.01B 3.26B | Net income 2025 * | 3.53B 3.83B | EV / Sales 2024 * | 3.68 x |
Net Debt 2024 * | 6.09B 6.61B | Net Debt 2025 * | 4.41B 4.79B | EV / Sales 2025 * | 3.4 x |
P/E ratio 2024 * |
24
x | P/E ratio 2025 * |
20.4
x | Employees | 62,345 |
Yield 2024 * |
1.36% | Yield 2025 * |
1.47% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | +1.12% | ||
1 week | -0.75% | ||
1 month | +11.78% | ||
3 months | +5.51% | ||
6 months | +3.97% | ||
Current year | +15.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 54 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Chairman | 67 | 19-04-25 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.34% | 2 M€ | +13.56% | - | |
2.01% | 0 M€ | -.--% | - | |
1.80% | 962 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 166.5 | +1.12% | 568,222 |
24-05-30 | 164.6 | -2.28% | 324,904 |
24-05-29 | 168.5 | +0.51% | 257,213 |
24-05-28 | 167.6 | +0.15% | 136,730 |
24-05-27 | 167.4 | -0.21% | 117,979 |
Delayed Quote Xetra, May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock